|
Free Research Articles
Citations 161-170 of 789 total displayed.
|
Past content
(since May 2004):
|
Dose-dense induction with sequential high-dose cytarabine and mitoxantone (S-HAM) and pegfilgrastim results in a high efficacy and a short duration of critical neutropenia in de novo acute myeloid leukemia: a pilot study of the AMLCG
- Jan Braess, Karsten Spiekermann, Peter Staib, Andreas Grüneisen, Bernhard Wörmann, Wolf-Dieter Ludwig, Hubert Serve, Albrecht Reichle, Rudolf Peceny, Daniel Oruzio, Christoph Schmid, Xaver Schiel, Marcus Hentrich, Christina Sauerland, Michael Unterhalt, Michael Fiegl, Wolfgang Kern, Christian Buske, Stefan Bohlander, Achim Heinecke, Herrad Baurmann, Dietrich W. Beelen, Wolfgang E. Berdel, Thomas Büchner, and Wolfgang Hiddemann
Blood 2009; 113: 3903-3910.
[Abstract]
[Full text]
[PDF]
Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival
- Grace H. Ku, Richard H. White, Helen K. Chew, Danielle J. Harvey, Hong Zhou, and Ted Wun
Blood 2009; 113: 3911-3917.
[Abstract]
[Full text]
[PDF]
Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project
- Wing-yan Au, Dennis D. Weisenburger, Tanin Intragumtornchai, Shigeo Nakamura, Won-Seog Kim, Ivy Sng, Julie Vose, James O. Armitage, Raymond Liang, and for the International Peripheral T-Cell Lymphoma Project
Blood 2009; 113: 3931-3937.
[Abstract]
[Full text]
[PDF]
Differentiation therapy of leukemia: 3 decades of development
- Daniel Nowak, Daphne Stewart, and H. Phillip Koeffler
Blood 2009; 113: 3655-3665.
[Abstract]
[Full text]
[PDF]
Improved patient survival for acute myeloid leukemia: a population-based study of 9729 patients diagnosed in Sweden between 1973 and 2005
- Åsa Rangert Derolf, Sigurdur Yngvi Kristinsson, Therese M.-L. Andersson, Ola Landgren, Paul W. Dickman, and Magnus Björkholm
Blood 2009; 113: 3666-3672.
[Abstract]
[Full text]
[PDF]
Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia
- Steven P. Treon, Andrew R. Branagan, Leukothea Ioakimidis, Jacob D. Soumerai, Christopher J. Patterson, Barry Turnbull, Parveen Wasi, Christos Emmanouilides, Stanley R. Frankel, Andrew Lister, Pierre Morel, Jeffrey Matous, Stephanie A. Gregory, and Eva Kimby
Blood 2009; 113: 3673-3678.
[Abstract]
[Full text]
[PDF]
Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival
- Nathalie A. Johnson, Merrill Boyle, Ali Bashashati, Stephen Leach, Angela Brooks-Wilson, Laurie H. Sehn, Mukesh Chhanabhai, Ryan R. Brinkman, Joseph M. Connors, Andrew P. Weng, and Randy D. Gascoyne
Blood 2009; 113: 3773-3780.
[Abstract]
[Full text]
[PDF]
Rituximab immunotherapy results in the induction of a lymphoma idiotype-specific T-cell response in patients with follicular lymphoma: support for a "vaccinal effect" of rituximab
- Shannon P. Hilchey, Ollivier Hyrien, Tim R. Mosmann, Alexandra M. Livingstone, Jonathan W. Friedberg, Faith Young, Richard I. Fisher, Raymond J. Kelleher, Jr, Richard B. Bankert, and Steven H. Bernstein
Blood 2009; 113: 3809-3812.
[Abstract]
[Full text]
[PDF]
Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention
- Eleftherios C. Vamvakas and Morris A. Blajchman
Blood 2009; 113: 3406-3417.
[Abstract]
[Full text]
[PDF]
Dendritic cell homeostasis
- Miriam Merad and Markus G. Manz
Blood 2009; 113: 3418-3427.
[Abstract]
[Full text]
[PDF]
|
|
